We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+6.26%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$864M
AUM Growth
+$54.1M
Cap. Flow
+$8.09M
Cap. Flow %
0.94%
Top 10 Hldgs %
50.84%
Holding
197
New
11
Increased
61
Reduced
63
Closed
13

Top Buys

Rank Stock Value
1
FNDX icon
Schwab Fundamental US Large Company Index ETF
FNDX
+$6.54M
2
SCHF icon
Schwab International Equity ETF
SCHF
+$2.93M
3
FNDF icon
Schwab Fundamental International Large Company Index ETF
FNDF
+$2.51M
4
SCHB icon
Schwab US Broad Market ETF
SCHB
+$1.79M
5
AVUV icon
Avantis US Small Cap Value ETF
AVUV
+$1.76M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$2.53M
2
JMST icon
JPMorgan Ultra-Short Municipal Income ETF
JMST
+$2.27M
3
VO icon
Vanguard Morningstar Mid-Cap ETF
VO
+$1.22M
4
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$1.1M
5
GSLC icon
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
+$803K

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.85%
2 Technology 3.67%
3 Financials 1.29%
4 Healthcare 1.17%
5 Real Estate 0.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VB icon
151
Vanguard Morningstar Small-Cap ETF
VB
$81.3B
$275K 0.03%
1,451
– –
GM icon
152
General Motors
GM
$75.7B
$265K 0.03%
7,216
– –
PYPL icon
153
PayPal
PYPL
$45.9B
$261K 0.03%
3,439
+40
+1% +$3.08K
INGN icon
154
Inogen
INGN
$146M
$257K 0.03%
+20,611
New +$395K
PM icon
155
Philip Morris
PM
$299B
$255K 0.03%
2,626
– –
UNH icon
156
UnitedHealth
UNH
$353B
$249K 0.03%
526
-418
-44% -$202K
BMY icon
157
Bristol-Myers Squibb
BMY
$136B
$248K 0.03%
3,575
– –
BA icon
158
Boeing
BA
$166B
$247K 0.03%
1,164
– –
IG icon
159
Principal Investment Grade Corporate Active ETF
IG
$202M
$247K 0.03%
11,762
– –
TLTD icon
160
Northern Trust Morningstar Developed Markets ex-US Factor Tilt ETF
TLTD
$690M
$244K 0.03%
3,785
+7
+0.2% +$447
LLY icon
161
Eli Lilly
LLY
$1.05T
$234K 0.03%
682
-130
-16% -$43.8K
VV icon
162
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
$230K 0.03%
1,231
– –
PANW icon
163
Palo Alto Networks
PANW
$303B
$230K 0.03%
+2,298
New +$195K
LOW icon
164
Lowe's Companies
LOW
$117B
$229K 0.03%
1,143
– –
LIN icon
165
Linde
LIN
$226B
$228K 0.03%
641
– –
XOM icon
166
ExxonMobil
XOM
$644B
$221K 0.03%
2,019
– –
PXH icon
167
Invesco FTSE RAFI Emerging Markets ETF
PXH
$2.01B
$220K 0.03%
+11,986
New +$222K
IQV icon
168
IQVIA
IQV
$43.1B
$214K 0.02%
1,074
– –
AZN icon
169
AstraZeneca
AZN
$252B
$211K 0.02%
1,524
– –
PSTX
170
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$209K 0.02%
68,007
+5,660
+9% +$33.9K
CRM icon
171
Salesforce
CRM
$211B
$209K 0.02%
+1,048
New +$177K
XBI icon
172
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$201K 0.02%
2,635
– –
TARS icon
173
Tarsus Pharmaceuticals
TARS
$3.15B
$180K 0.02%
14,300
+2,700
+23% +$39.5K
LDP icon
174
Cohen & Steers Duration Preferred & Income Fund
LDP
$601M
$178K 0.02%
+10,000
New +$197K
ET icon
175
Energy Transfer Partners
ET
$73.4B
$140K 0.02%
+11,246
New +$142K
4 5 6
7
8

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Callan Capital held 197 positions worth $864M, up 6.7% from $810M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Callan Capital's Q1 2023 filing shows 11 new, 61 increased, 63 reduced and 13 closed positions. Its largest new stake was Avantis US Small Cap Value ETF: 22,447 shares worth $1.66M. The largest sale was Jazz Pharmaceuticals, an estimated $2.53M.

By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, up from 90% a quarter earlier, followed by Technology and Financials.

  • Callan Capital's largest Q1 2023 buy was Avantis US Small Cap Value ETF: 22,447 shares worth $1.66M.
  • Callan Capital added most to Schwab Fundamental US Large Company Index ETF in Q1 2023, an estimated $6.54M increase.
  • Callan Capital's biggest Q1 2023 reduction was JPMorgan Ultra-Short Municipal Income ETF, cutting an estimated $2.27M.
  • Callan Capital fully exited Jazz Pharmaceuticals in Q1 2023, selling an estimated $2.53M.
  • Callan Capital's ten largest holdings make up 51% of its $864M portfolio in Q1 2023.
  • Callan Capital opened 11 new positions and closed 13 in Q1 2023.
  • Callan Capital's portfolio value rose 6.7% quarter-over-quarter to $864M.

Based on Callan Capital's 13F filing for Q1 2023, filed 9 May 2023.